OA09023A - Pharmaceutical composition, which can be administered orally, intended to reduce the effects of b-lactams. - Google Patents

Pharmaceutical composition, which can be administered orally, intended to reduce the effects of b-lactams.

Info

Publication number
OA09023A
OA09023A OA59487A OA59487A OA09023A OA 09023 A OA09023 A OA 09023A OA 59487 A OA59487 A OA 59487A OA 59487 A OA59487 A OA 59487A OA 09023 A OA09023 A OA 09023A
Authority
OA
OAPI
Prior art keywords
lactams
effects
intended
reduce
pharmaceutical composition
Prior art date
Application number
OA59487A
Other languages
French (fr)
Inventor
Tancrede Cyrille
Andremont Antoine
Labia Roger
Leonard Florence
Original Assignee
Roussy Inst Gustave
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussy Inst Gustave filed Critical Roussy Inst Gustave
Publication of OA09023A publication Critical patent/OA09023A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
OA59487A 1987-04-10 1988-12-09 Pharmaceutical composition, which can be administered orally, intended to reduce the effects of b-lactams. OA09023A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8705110A FR2613624B1 (en) 1987-04-10 1987-04-10 ORAL ADMINISTRATIVE PHARMACEUTICAL COMPOSITION FOR REDUCING THE EFFECTS OF B-LACTAMINES

Publications (1)

Publication Number Publication Date
OA09023A true OA09023A (en) 1991-03-31

Family

ID=9350003

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59487A OA09023A (en) 1987-04-10 1988-12-09 Pharmaceutical composition, which can be administered orally, intended to reduce the effects of b-lactams.

Country Status (8)

Country Link
EP (1) EP0309532A1 (en)
JP (1) JPH01503537A (en)
AU (1) AU604117B2 (en)
FR (1) FR2613624B1 (en)
OA (1) OA09023A (en)
PT (1) PT87190B (en)
WO (1) WO1988007865A1 (en)
ZA (1) ZA882426B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI920206A0 (en) * 1992-01-17 1992-01-17 Pekka Untamo Heino MEDICINSK ANVAENDNING, MEDICINSKT FOERFARANDE OCH PREPARAT.
FR2843302B1 (en) * 2002-08-09 2004-10-22 Centre Nat Rech Scient GALENIC FORM FOR COLLECTIVE DELIVERY OF ACTIVE PRINCIPLES
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
FI20105572A0 (en) 2010-05-24 2010-05-24 Prevab R Lcc Modified beta-lactamase and methods and uses related thereto
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
BR112016023360B1 (en) 2014-04-17 2023-03-07 Synthetic Biologics, Inc BETA-LACTAMASE AND ITS USE
JP6803328B2 (en) 2014-08-28 2021-01-06 シンセティック バイオロジクス，インコーポレイテッド E. coli-based beta-lactamase production
WO2016057744A1 (en) 2014-10-08 2016-04-14 Synthetic Biologics, Inc. Beta-lactamase formulations and uses thereof
EP3236993B1 (en) 2014-12-23 2023-09-13 Theriva Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
EP3400953A1 (en) 2014-12-23 2018-11-14 4D Pharma Research Limited Pirin polypeptide and immune modulation
AR103260A1 (en) 2014-12-23 2017-04-26 4D Pharma Res Ltd IMMUNE MODULATION
EP3261662B1 (en) 2015-02-23 2021-07-21 Synthetic Biologics Inc. Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
EP3265119B1 (en) 2015-03-06 2023-10-11 Theriva Biologics, Inc. Safe and effective beta-lactamase dosing for microbiome protection
WO2016203221A1 (en) 2015-06-15 2016-12-22 4D Pharma Research Limited Compositions comprising bacterial strains
NZ737752A (en) 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41010B1 (en) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprising bacterial strains
SMT201900588T1 (en) 2015-06-15 2019-11-13 4D Pharma Res Limited Blautia stercosis and wexlerae for use in treating inflammatory and autoimmune diseases
MA41060B1 (en) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108513545B (en) 2015-11-20 2020-11-03 4D制药研究有限公司 Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
ME03487B (en) 2016-03-04 2020-01-20 4D Pharma Plc BACTERIAL BLAUTIA STRAIN COMPOSITIONS FOR THE TREATMENT OF VISCERAL HIGH SENSITIVITY
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TWI802545B (en) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 Compositions comprising bacterial strains
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
DK3630136T3 (en) 2017-05-22 2021-05-25 4D Pharma Res Ltd COMPOSITIONS INCLUDING BACTERIA STRAINS
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
CA3066189A1 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
SMT202000555T1 (en) 2017-06-14 2020-11-10 4D Pharma Res Limited Compositions comprising a bacterial strain of the genus megasphaera and uses thereof
SMT202000695T1 (en) 2017-06-14 2021-01-05 4D Pharma Res Limited Compositions comprising bacterial strains

Also Published As

Publication number Publication date
PT87190A (en) 1988-05-01
EP0309532A1 (en) 1989-04-05
PT87190B (en) 1992-08-31
WO1988007865A1 (en) 1988-10-20
FR2613624A1 (en) 1988-10-14
ZA882426B (en) 1988-09-28
AU604117B2 (en) 1990-12-06
AU1578688A (en) 1988-11-04
FR2613624B1 (en) 1990-11-23
JPH01503537A (en) 1989-11-30

Similar Documents

Publication Publication Date Title
OA09023A (en) Pharmaceutical composition, which can be administered orally, intended to reduce the effects of b-lactams.
DZ1077A1 (en) New pharmaceutical preparation for oral administration.
FR2523443B1 (en) NOVEL PHARMACEUTICAL FORMULATIONS CONTAINING COENZYME Q10 SUITABLE FOR TOPICAL ADMINISTRATION
IE862554L (en) Pharmaceutical compositions
PT87820A (en) PROCESS FOR THE PREPARATION OF 1,2,3,5,6-TETRAHYDRO-PYRIDILE ANOF PYPERIDILE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREWI
MX9203263A (en) ANALGESICAL PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.
BE849632A (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
IT1210666B (en) PERCUTANEOUS PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ANGINA PECTORIS
IT8619625A0 (en) PHARMACEUTICAL COMPOSITIONS FOR INHALATION.
IT8621358A0 (en) PHARMACEUTICAL COMPOSITION ANALGESIC ADAPTIVITY.
FI903759A7 (en) Orally administrable pharmaceutical composition containing N-acetyl-cysteine
IT8119673A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOPATHIES.
MA22443A1 (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION.
FI883673A7 (en) PHARMACEUTICAL COMPOSITIONS.
ATE90339T1 (en) BASIC SUBSTITUTED PHENYLACETONITRILES, THEIR PREPARATION AND MEDICATIONS CONTAINING THEM.
FI874414A7 (en) Controlled-release pharmaceutical compositions.
IT8722031A0 (en) PHARMACEUTICAL FORMULATIONS AND DOSAGE FORMS FOR THE RECTAL ADMINISTRATION OF CALCITONIN.
IT1210935B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
NO873514L (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL ACTIVE COMPOUNDS.
OA06135A (en) Pharmaceutical composition for oral administration.
IT8722647A0 (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.
OA08609A (en) Pharmaceutical composition for the treatment of bacterial infections.
FR2673105B1 (en) NOVEL PHARMACEUTICAL COMPOSITIONS, ESPECIALLY FOR THE TREATMENT OF FUNCTIONAL COLOPATHIES, AND METHODS OF PREPARING COMPOSITIONS AND MEDICAMENTS, ESPECIALLY FOR THE TREATMENT OF THESE CONDITIONS.
FR2685204B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TRANSCUTANEOUS ADMINISTRATION OF FENFLURAMINE.